ATE351T1 - Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen. - Google Patents

Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE351T1
ATE351T1 AT79103473T AT79103473T ATE351T1 AT E351 T1 ATE351 T1 AT E351T1 AT 79103473 T AT79103473 T AT 79103473T AT 79103473 T AT79103473 T AT 79103473T AT E351 T1 ATE351 T1 AT E351T1
Authority
AT
Austria
Prior art keywords
acid addition
optical isomer
phenylalkylaminoaethylsalicylamide
derivative
preparation
Prior art date
Application number
AT79103473T
Other languages
German (de)
English (en)
Inventor
Elijah Herman Gold
Wei Chang
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Application granted granted Critical
Publication of ATE351T1 publication Critical patent/ATE351T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/12Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/65Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Epoxy Compounds (AREA)
AT79103473T 1978-09-20 1979-09-17 Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen. ATE351T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94451678A 1978-09-20 1978-09-20
EP79103473A EP0009702B1 (en) 1978-09-20 1979-09-17 A phenylalkylaminoethylsalicylamide, its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
ATE351T1 true ATE351T1 (de) 1981-11-15

Family

ID=25481553

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79103473T ATE351T1 (de) 1978-09-20 1979-09-17 Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.

Country Status (27)

Country Link
EP (1) EP0009702B1 (en])
JP (3) JPS5555147A (en])
KR (2) KR830000904A (en])
AT (1) ATE351T1 (en])
AU (1) AU528626B2 (en])
CA (1) CA1151211A (en])
CY (1) CY1175A (en])
DD (1) DD150457A5 (en])
DE (1) DE2961263D1 (en])
DK (1) DK387579A (en])
FI (1) FI792884A7 (en])
GR (1) GR73179B (en])
HK (1) HK13383A (en])
HU (1) HU185523B (en])
IE (1) IE49301B1 (en])
IL (1) IL58258A (en])
KE (1) KE3283A (en])
MY (1) MY8500042A (en])
NO (1) NO149660C (en])
NZ (1) NZ191589A (en])
OA (1) OA06339A (en])
PH (1) PH16794A (en])
PL (1) PL129114B1 (en])
PT (1) PT70191A (en])
SG (1) SG283G (en])
YU (1) YU227379A (en])
ZA (1) ZA794872B (en])

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4658060A (en) * 1982-04-26 1987-04-14 Schering Corporation Preparation of (-)-5-(beta)-1-hydroxy-2-((beta)-1-methyl-3-phenylpropyl)aminoethyl) salicylamide
IT1194406B (it) * 1983-09-27 1988-09-22 Scharper S P A Procedimento per la preparazione di 2-idrossi-5-01-idrossi-2-((4-fenil-2-butil)ammino) etil benzammide
HU190867B (en) * 1984-01-20 1986-11-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing 2-hydroxy-5-/1-hydroxy-2-/1-methyl-3-phenyl-propyl/-amino/ethyl/-benzamide and pharmaceutically acceptable salts thereof
US4788183A (en) * 1987-11-30 1988-11-29 Schering Corporation Method for treatment of dyslipidemia in humans
US4879233A (en) * 1989-02-10 1989-11-07 Schering Corporation Novel Aspergillus niveus microorganism used for the chiral reduction of carbonyl groups
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
KR100251995B1 (ko) * 1991-08-23 2000-06-01 젠센 제임스 유. 칼슘 수용체 활성 분자
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
ES2234768T3 (es) 1994-10-21 2005-07-01 Nps Pharmaceuticals, Inc. Compuestos capaces de modular la actividad del receptor de calcio.
DE69739388D1 (de) 1996-05-01 2009-06-10 Nps Pharma Inc Inorganische am Ionen-Rezeptor aktive Verbindungen
IT1313583B1 (it) 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
EP1961735B1 (en) * 2007-02-22 2009-11-18 Indena S.P.A. Process for the preparation of (2r,3s)-3-phenylisoserine methyl ester acetate salt
JP6245983B2 (ja) 2010-08-11 2017-12-13 ドレクセル ユニバーシティ パーキンソン病におけるジスキネジアを治療するための新規d3ドーパミン受容体アゴニスト

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1266058A (en]) * 1969-07-08 1972-03-08
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
NL7603965A (nl) * 1975-04-17 1976-10-19 Scherico Ltd Diastereoisomeren van fenylaminoethanolderi- vaten met farmacologische activiteit en werk- wijzen om deze te bereiden.

Also Published As

Publication number Publication date
AU5088179A (en) 1980-03-27
KR840005307A (ko) 1984-11-05
SG283G (en) 1983-09-16
IE49301B1 (en) 1985-09-18
EP0009702A1 (en) 1980-04-16
NZ191589A (en) 1984-03-30
HK13383A (en) 1983-04-29
PH16794A (en) 1984-02-28
YU227379A (en) 1983-06-30
CY1175A (en) 1983-06-10
NO149660C (no) 1984-05-30
EP0009702B1 (en) 1981-11-04
KR890001998B1 (ko) 1989-06-07
MY8500042A (en) 1985-12-31
IE791770L (en) 1980-03-20
KR830000904A (ko) 1983-04-28
GR73179B (en]) 1984-02-14
PT70191A (en) 1979-10-01
DE2961263D1 (en) 1982-01-14
HU185523B (en) 1985-02-28
JPS59108749A (ja) 1984-06-23
IL58258A0 (en) 1979-12-30
CA1151211A (en) 1983-08-02
JPH02167253A (ja) 1990-06-27
NO792993L (no) 1980-03-21
NO149660B (no) 1984-02-20
OA06339A (fr) 1981-06-30
DK387579A (da) 1980-03-21
ZA794872B (en) 1980-11-26
AU528626B2 (en) 1983-05-05
JPH0210128B2 (en]) 1990-03-06
FI792884A7 (fi) 1981-01-01
PL218408A1 (en]) 1980-09-08
KE3283A (en) 1983-05-13
PL129114B1 (en) 1984-03-31
DD150457A5 (de) 1981-09-02
JPS5555147A (en) 1980-04-22
IL58258A (en) 1984-01-31

Similar Documents

Publication Publication Date Title
ATE351T1 (de) Phenylalkylaminoaethylsalicylamid-derivat, seine herstellung und es enthaltende pharmazeutische zusammensetzungen.
EP0389282A3 (en) Xanthinederivatives, process for their preparation and their pharmaceutical use
ES2081187T3 (es) Nuevas naftil-alquil-aminas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69030206D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
DE68919010D1 (de) Purinverbindungen, Verfahren zu ihrer Herstellung und pharmazeutische Präparate.
KR890011902A (ko) 디데옥시디데히드로카르보시클릭 뉴클레오시드
DE69215965D1 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
ES2179996T3 (es) Cefalosporinas de vinil-pirrolidinona con sustituyentes basicos.
NO902800D0 (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
AU6652390A (en) Compositions and their use in lowering intraocular pressure
ES2118203T3 (es) Nuevos derivados benzopiranicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NO157643C (no) Anvendelse av sitronsyre for aa forhindre nedbrytning av farmasoeytisk taalbare syreaddisjonssalter av tienopyridinderivater.
ATE2622T1 (de) 2-niedrigalkyl-7-substituierte-2 oder 3-cephem-4- carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE204278T1 (de) Serotoninergische ergolin derivate
WO1990003172A3 (en) Bile acids for treatment of viral infections
SE7607300L (sv) Tiaxantenforeningar samt forfarande for framstellning av dem
BR8304268A (pt) Composicoes fungicidas e processos para o combate de fungos, para a protecao de plantas e para a preparacao de composicoes
DK105183D0 (da) Fremgangsmade til fremstilling af 1,4-diaminocyclitolderivater
GB2316406A (en) Free radical scavenger molecules
ZA933942B (en) Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them
KR890003678A (ko) 부정맥 치료제
RU99125836A (ru) Фармацевтические композиции, содержащие производные гидроксамовой кислоты

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee